Back to search

Ireland· IE-PA-EU/1/24/1882/001-002

SIILTIBCY (0.5 microgram + 0.5 microgram)/mL solution for injection

A tuberculosis diagnostics product containing rdesat-6 + rcfp-10, registered in Ireland by Vakzine Projekt Management GmbH. The same ATC class is registered in 2 of our 19 countries.

ATC V04CF

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedSIILTIBCY (0.5 microgram + 0.5 microg…ATCV04CFREGISTER NO.IE-PA-EU/1/24/1882/00…PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Rdesat-6 + rcfp-10 is registered in 2 of 19 countries.

Countries holding a registration under ATC V04CF (tuberculosis diagnostics), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)

Rdesat-6 + rcfp-10 · ATC V04CF

2 / 19 countries

  • Denmark
  • Ireland
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
rdESAT-6 + rCFP-10
Manufacturer
Vakzine Projekt Management GmbH
Country
Ireland (IE)
ATC code
V04CF
ATC class
Tuberculosis diagnostics
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/24/1882/001-002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V04CF

Tuberculosis diagnostics, as other registers publish it.

All rdesat-6 + rcfp-10 products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aeb939c3-12f2-4bd2-8061-b07db604034e
GET /v1/drugs/aeb939c3-12f2-4bd2-8061-b07db604034e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "routes": [
    "Intradermal use"
  ],
  "source": "hpra",
  "atc_all": [
    "V04CF"
  ],
  "strength": null,
  "pa_number": "EU/1/24/1882/001-002",
  "substances": [
    "rdESAT-6",
    "rCFP-10"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "13/01/2025",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about rdesat-6 + rcfp-10.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.